The global skin cancer diagnosis and therapeutics market are growing at a considerable CAGR of around 7.5% during the forecast period. The factor driving the growth of the market include the prevalence of skin cancer, rising incidence of skin cancer, increasing R&D pipelines. The risk factors for skin cancer include sunlamps and tanning booths, sunlight, and certain medical conditions. As per the American Cancer Society exposure to the sun is the most unavoidable risk factor for all skin cancers. According to (World Health Organization) WHO, it is estimated that more than 1,20 million people across the globe are diagnosed with non-melanoma cancer in 2021. According to the estimates of the Skin Cancer Foundation, one in every five Americans is likely to be diagnosed with a kind of skin cancer during their lifetime.
Free Sample Copy @ https://www.omrglobal.com/request-sample/skin-cancer-diagnosis-and-therapeutics-market
The market is segmented based on type, therapy, and diagnosis. Based on type the market is segmented into melanoma and non-melanoma. Based on therapy the market is segmented into surgery treatment, radiotherapy, chemotherapy, targeted therapy, immunotherapy, and others. Based on diagnosis the market is segmented into dermatoscopy, biopsy, blood test, X-Rays, and others.
A Full Report of Global Skin Cancer Diagnosis and Therapeutics Market is Available at:
https://www.omrglobal.com/industry-reports/skin-cancer-diagnosis-and-therapeutics-market
The global skin cancer diagnosis and therapeutics market are analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in 2020 in the global skin cancer diagnosis and therapeutics market. Some factors are boosting the market growth in the region. According to the American Academy of Dermatology, Skin cancer is one of the most common cancer in the US and Canada. An estimated 106,110 new cases of invasive melanoma and 101,280 cases of in situ melanoma will be diagnosed in the US in 2021. It is projected that around 9,500 people in the US are diagnosed with skin cancer every day. The rising cases of skin cancer in the region is the main factor driving the growth of the market.
Global Skin Cancer Diagnosis and Therapeutics Market – Segmentation
By Type
Melanoma
Non-Melanoma
By Therapy
Surgery treatment
Radiotherapy
Chemotherapy
Targeted therapy
Immunotherapy
Others(Laser therapy, freezing, scraping)
By Diagnosis
Dermatoscopy
Biopsy
Blood test
X-rays
Others(CT Scan)
Global Skin Cancer Diagnosis and Therapeutics Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Agilent technologies
Amgen, Inc.
Aqua pharmaceuticals LLC
AstraZeneca PLC
Bausch Health Companies Inc.
Bristol Myers Squibb co.
Daiichi Sankyo Co. Ltd.
Elekta AB
Eli Lilly and Co.
Glaxosmithkline PLC
F. Hoffmann-La Roche Ltd.
IcadInc.
Merck & co. Inc.
Mylan N.V.
Novartis International AG
Pfizer Inc.
Qiagen GmbH
Sanofi S.A.
Teva pharmaceuticals Industries Ltd.
Varian medical systems Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/skin-cancer-diagnosis-and-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
(This release has been published on Global Market Post.
Global Market Post is not responsible for any content included in this release.)
